Abbott Laboratories (ABT) Leases (2019 - 2025)

Abbott Laboratories' Leases history runs 7 years deep, the most recent figure standing at $1.1 billion for Q4 2025.

• In Q4 2025, Leases rose 4.74% year-over-year to $1.1 billion; the TTM figure through Dec 2025 stood at $1.1 billion (up 4.74% YoY), while the FY2025 annual figure was $1.1 billion, up 4.74% from the prior year.
• Leases came in at $1.1 billion for Q4 2025 at Abbott Laboratories, up from $1.1 billion in the prior quarter.
• In the past five years, Leases ranged from a high of $1.2 billion in Q4 2021 to a low of $1.1 billion in Q4 2024.
• A 5-year average of $1.1 billion and a median of $1.1 billion in 2023 frame the typical range for Leases.
• Across the five-year window, Leases retreated 4.19% in 2024 and increased 4.74% in 2025, its largest moves.
• Abbott Laboratories' Leases stood at $1.2 billion in 2021, then fell by 3.21% to $1.1 billion in 2022, then advanced by 0.54% to $1.1 billion in 2023, then retreated by 4.19% to $1.1 billion in 2024, then rose by 4.74% to $1.1 billion in 2025.
• According to Business Quant data, Leases over the past three periods registered $1.1 billion, $1.1 billion, and $1.1 billion for Q4 2025, Q4 2024, and Q4 2023 respectively.

Peer Comparison